Artificial intelligence methods now span the drug-discovery pipeline—structure prediction, de novo design, docking, affinity estimation, and ADMET—yet each tool ships with its own, often incompatible, GPU software stack, so chaining several into a workflow requires reproducing conflicting software environments and access to datacenter-class hardware that most labs do not have. bioq is a dependency-light command-line client backed by bioq-services (a control-plane gateway plus a growing fleet of 38+ containerized drug-discovery tools spanning 7 discovery stages and 6 molecular modalities). The bioq CLI is self-describing and consistent across the fleet of computational tools, giving researchers and coding agents uniform access to any tool from a laptop, with no local model code, CUDA setup, or cloud configuration, running on serverless GPUs billed per job. The interface–gateway–services architecture makes bioq an execution substrate for automated, agent-driven discovery. bioq and bioq-services are open source under the MIT License and available at https://github.com/wolfsonliu/bioq and https://github.com/wolfsonliu/bioq-services. bioq runs on Python ≥ 3.10 with httpx as its only runtime dependency; services run as Linux containers and are self-hostable via the provided local deployment scripts (alongside scripts for Alibaba Cloud Function Compute). Install, quickstart, test data, and self-hosting instructions are in the repository. The project is actively maintained and will continue to receive updates to both features and services.
Results indicate that DDA provides a scalable, executable, and traceable computational framework that reduces manual coordination in structure-based automated drug discovery and delivers prioritized candidate sets with minimal human intervention.
Yu-Tao Yu, Si-Cheng Tian, Guo-Hua Wang et al.· Frontiers in Chemistry· 0 citations
Accelerating the identification of viable drug candidates across therapeutic areas demands autonomous systems for molecular generation that enforce chemical correctness by structural invariants rather than model capability. We present MolecureAI, an autonomous AI agent architecture for closed-loop drug discovery with...
M. Chadi, Asmaa Amzil, Hajar Ezzahoud et al.· Frontiers in Pharmacology· 0 citations
ALKEMIE Agent is introduced, an agentic platform in which retrieval-augmented generation, a materials-computation knowledge base, registered skills, database-supported provenance, AI-assisted structure modeling, bounded task execution, tool-calling iteration, and error-diagnostic assistance are integrated within a trac...
ASEND (Autonomous Scientific Computing Engine and Novel Discovery), an AI-powered agent system, operated through a command-line or a local web chat interface, that runs the agent on the researcher's own laptop, reaching Slurm clusters and a GPU workstation over multiplexed authenticated SSH, with site-specific executio...
J. P. Liu, Uthpala Herath, Andrew Petersen· 0 citations
Modern drug discovery joins machine learning with physics-based simulation, but building such a pipeline needs Linux administration, dependency management, format conversion and scripting, which keeps out many of the chemists and biologists who ask the questions. We describe SilicoXplore, a cloud-hosted platform of 31...
Parth Mangal, O. Shinde, Sonali Chikhale et al.· Journal of Molecular Graphic...· 0 citations
Related blog posts
Microsoft Research Blog· microsoft.comOct 12, 2026
StudentSim is a research system for evaluating and improving AI tutoring tools before they are tested with learners. It models how individuals may engage with tutors, giving feedback to improve tutor performance across subjects like chess, writing, and mathematics. The post Simulating student learning for better AI tutoring appeared first on Microsoft Research.
MIT News · Artificial Intelligence· news.mit.eduOct 6, 2026
Writing as a participant and researcher, PhD student JS Tan SM ’22 has co-authored a new book about the rise of tech worker protests and the employer backlash that followed.
MIT News · Artificial Intelligence· news.mit.eduOct 2, 2026
Writing as a participant and researcher, PhD student JS Tan SM ’22 has co-authored a new book about the rise of tech worker protests and the employer backlash that followed.
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.